AI Therapist Matches Human Care in Groundbreaking Mental Health Trial
Posted:
People struggling with depression who used an artificial intelligencetherapy app for just four weeks experienced a 51% reduction in symptoms—matching results typically seen with human therapists, according to the first clinical trial of its kind.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…
From detecting TB, cancer, and heart attacks to diagnosing patients with strokes and diabetes, Artificial Intelligence (AI) is redefining the healthcare system across the world. Currently, more than 90% of hospitals and healthcare systems have implemented an AI or automation strategy,…